Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery
about
Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug deliveryDirect cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsulesGold Nanoparticles in Single-Cell Analysis for Surface Enhanced Raman ScatteringRole of Physicochemical Properties in Nanoparticle ToxicityTheranostic Performance of Acoustic Nanodroplet Vaporization-Generated Bubbles in Tumor Intertissue.Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers.Nanomedicine strategies for molecular targets with MRI and optical imaging.Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.Conquering the dark side: colloidal iron oxide nanoparticles.Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumorsCharacterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulationsSulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.Intracellular pH measurements using perfluorocarbon nanoemulsionsalphaVbeta3-targeted copper nanoparticles incorporating an Sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment.Role of lipid rafts in liver health and diseaseContact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticlesDual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat.Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective.Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.Host-cell lipid rafts: a safe door for micro-organisms?Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials.Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.Lipid-based nanoparticles in the systemic delivery of siRNA.Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a "relaxation switch" for detecting cellular endosomal activation.Unraveling the role of membrane microdomains during microbial infections.Cell specific peptide-conjugated polysaccharide nanogels for protein delivery.Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.Nano "Chocolate Waffle" for near-IR Responsive Drug Releasing System.Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrugSuppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.Transduction of peptides and proteins into live cells by cell penetrating peptides.Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles.Rod-Shaped Active Drug Particles Enable Efficient and Safe Gene Delivery.
P2860
Q26795703-C79892B1-323F-400D-A00D-1107619B26B7Q27339704-66396999-04AC-4164-B8A0-F3BB075D408AQ28079121-41C385E8-86CF-4ACA-AEE8-C56D8F0C365AQ29248830-50C3A2BE-D779-45C8-B85E-95AF843695D2Q30356036-B7B041B0-74CE-444F-9430-76DC902A68ACQ30385272-08E7C422-7DFE-4CBC-A7AE-99FCA27021AFQ30459662-060A41EF-ED7D-489A-877C-BEF1C5D84524Q30481471-02A2AF88-3051-4A54-BC0C-7A6784126E13Q30486235-B5C08669-5510-4127-AAC9-F5E241B13099Q33554945-1603BB31-8B54-4070-B377-B1C7E0DF760BQ33684461-0D96F758-038A-45DE-8E7A-BE3C5CADC8B2Q33855309-5029C985-0D05-4384-96A6-6DFC040D9C85Q34051542-3D3C0669-9FFC-48F6-A490-FFF5D5234505Q34094167-457E2547-0201-4A60-B077-08F77CD14842Q34399286-1B7BC000-C0AC-473F-97F5-C394CFDF04DEQ34785222-A347DFD4-CCFE-42F7-9512-CAFB6DFE9341Q35012726-E755A36B-9B10-411B-BFDB-74EE6706199CQ35164794-DF8CDB1B-09F3-40E9-8D42-43DC07638393Q36505441-E1D7BAE1-A032-426F-A989-92F5C6A070DFQ37328406-F2F11BF1-9F7C-4CA2-A078-3AD023575CD5Q37541992-5F59247E-7E85-4336-BC7B-0514225C2754Q37668445-BDB0D2C5-2B2C-43E4-AFCD-508D1EAFFD78Q37695396-B830DF2B-2FF1-40BB-9ACF-2A6E8409FB05Q37727270-3C110385-4186-4DA1-9D48-1C406E6284D8Q37771030-6276D281-32EE-4CCE-9734-61D7899F4156Q37804385-AA9FDA91-7EDE-4CBB-B61E-402371184899Q37827768-D9FBBCA9-75AE-4818-9AB1-08CFB5B0AAF2Q37869062-AEA2E472-702B-47AB-B710-822EA885A0BAQ37947952-28A774C2-7806-43BC-AFBB-88C6ABB9E8F1Q38172634-D261AB9F-8166-4DA3-B306-099F88094EF0Q38771628-E281C3DE-C204-4C3C-BD0E-04EA86904440Q39169754-DE1E4D45-44DD-48D2-95B3-8C2D88D5B875Q39558860-614EAA82-9032-418C-9B70-DCFE53C39F64Q39903431-8F1358E1-62DD-4EF1-85FB-96B1FEB68686Q40599271-3E0765AD-2760-4E20-AA3E-15513C53470FQ41141263-4B032E42-ABF9-484A-8A2D-512B4EB751E4Q41879624-9BCA84E6-956A-4702-93DA-319F2F3ADE48Q42807094-A3C0925C-A105-489F-8C75-5966C75CA34DQ43559547-7DF6FC93-2BAE-4043-9D01-58565F2D076CQ45875385-26B8C1EF-E28E-439D-9BBE-86019F20C533
P2860
Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exploiting lipid raft transpor ...... gy for cytosolic drug delivery
@en
Exploiting lipid raft transpor ...... y for cytosolic drug delivery.
@nl
type
label
Exploiting lipid raft transpor ...... gy for cytosolic drug delivery
@en
Exploiting lipid raft transpor ...... y for cytosolic drug delivery.
@nl
prefLabel
Exploiting lipid raft transpor ...... gy for cytosolic drug delivery
@en
Exploiting lipid raft transpor ...... y for cytosolic drug delivery.
@nl
P2093
P2860
P1433
P1476
Exploiting lipid raft transpor ...... gy for cytosolic drug delivery
@en
P2093
Gregory M Lanza
Kathryn C Partlow
Samuel A Wickline
P2860
P304
P356
10.1016/J.BIOMATERIALS.2008.04.030
P577
2008-05-16T00:00:00Z